A Tear-based, Lab-developed Test for Breast Cancer for Women With Dense Breast Tissue

Investigation of a tear-based, lab-developed biological test for breast cancer, as a supplemental tool to current screening recommendations for women with dense breast tissue will explore if a tear-based biological test can be used as a support tool in the breast cancer screening protocol for women with dense breast tissue. The test was designed and validated by Namida Lab, Inc., a high complexity Clinical Laboratory Improvement Amendments (CLIA) certified lab.

Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05268224.

Trial PhaseNo phase specified

Trial TypeNot provided by clinicaltrials.gov

Lead OrganizationNamida Lab

• Primary IDIRB#2022-0073
• Secondary IDsNCI-2022-05057, Melody_002
• ClinicalTrials.gov IDNCT05268224